Mr. Simon Castonguay reports

LUMIERA REPORTS SECOND QUARTER 2022 RESULTS WITH A 28% INCREASE COMPARED TO PREVIOUS YEAR

Lumiera Health Inc. has provided an update. The corporate strategy and plans that were put place in 2021 are continuing to prove successful with Lumiera's second quarter fiscal 2022 being another strong quarter with sales up 28 per cent versus Q2 2021.

The increase in the company's sales has been driven by increased retail and on-line distribution, which has led to trial and repeat purchases of Awaye natural pain relief cream and Bazzzics, a natural non-addictive sleep aid.

"We continue to receive outstanding feedback from Awaye and Bazzzics users. This positive feedback and the continued growth validates our strategies and plans. We have been expanding availability and distribution across Canada. We are very pleased with the performance of our team and partners in British Columbia, and we look forward to replicating that success in Ontario and the northeast [United States]," said Simon Castonguay, interim chief financial officer of Lumiera. "We will continue to invest in distribution expansion, trial and allocate more cash to inventory to enable us to capitalize on additional growth opportunities."

Q2 financial statements will be released on or before July 29, 2022.

About Lumiera Health Inc.

Lumiera specializes in the development and commercialization of consumer products for the natural health industry. The company sells herbal tonics and natural supplements through its Holizen Laboratories division, with a diverse portfolio including a line of innovative sleep aids. The company is also commercializing a unique topical product line acting on the endocannabinoid system, without the use of cannabis, that provides an innovative solution for chronic pain and inflammation. A pioneer in the natural health innovation space, the Lumiera brand is rooted in the core values of science, nature and compassion. Its goal is to make people's lives better by developing natural health and wellness products that are effective, safe and trustworthy.

We seek Safe Harbor.